Evaluation of agents/protocols that inhibit two major pathways involved in human urinary bladder cancer(PI3K, egfr) and protocols to reduce their toxicity
Ended Awarded Last action
- Contract number
- HHSN26100002
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $679,103
Award facts
- Opportunity
-
- 2015E02 Solicitation number
- Contract value 100% obligated
- $679,103.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $679,103 |
About this award
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to the University of Alabama at Birmingham (UAB). The contract is for the "Evaluation of Agents/Protocols that Inhibit Two Major Pathways Involved in Human Urinary Bladder Cancer (PI3K, EGFR) and Protocols to Reduce Their Toxicity." It is part of the NCI's Preclinical Prevention Cancer Program, which focuses on preclinical efficacy and intermediate endpoint biomarkers. The contract has a ceiling value of $679,103.00 and was awarded on September 24, 2015, with a final completion date of September 23, 2018. The contract type is a Delivery Order, with a Firm Fixed Price pricing mechanism. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 24, 2015.
How much is contract HHSN26100002 worth?
The government has obligated $679,103 on HHSN26100002.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN261201500036I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award